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Abstract 
Electronic transfer of prescriptions is an essential element of electronic medications management. Unfortunately, 
current manual and preliminary electronic transfer of prescription methods are not patient focussed, leading to a 
suboptimal solution for the patient. This is increasingly relevant in the push for more patient engagement in their 
own healthcare. The area is highly controlled by legislation and regulation. Through research and an analysis of 
the possible methods to improve and personalise electronic transfer of prescriptions, this paper provides an 
overview of these conclusions, and presents an alternative technical solution. The solution has been derived from 
a number of experiments in data transfer techniques using a mobile phone. The paper explains how this meets the 
current regulations and legislation, as well as providing a patient centred approach to the problem. Ultimately, 
healthcare outcomes will improve where patients are given the opportunity and the tools to better engage in their 
own healthcare management, and secure electronic transfer of prescriptions with patient access to their own 
medication lists may improve compliance and reduce healthcare costs.  
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INTRODUCTION 
The use of electronic prescription (eTP) is the lifeblood of eHealth and in improving quality of care through 
better medication compliance, improved prescribing accuracy and efficiency while reducing the adverse drug 
events. In fact, electronic prescribing is an essential initial step of the electronic Medication Management (eMM) 
program which primarily focuses on improving medication-related outcomes through better quality and 
availability of medications-related healthcare information (“NEHTA Blueprint V2”, 2011). Having an effective 
medication management system in place improves medication compliance and reduces adverse drug events. A 
recent study indicates almost 70,000 hospital admissions per year are associated with adverse drug events and 
poor medication compliance/adherence. This significantly contributes to having undesirable patient outcomes 
such as hospital readmission or even loss of life (White, 2015). The use of eTP enables eMM to reduce these 
undesirable outcomes and to prevent excessive use of healthcare expenditure while providing better patient 
safety. 
Current eTP implementation converts the conventional manual prescription process/model to a digital equivalent 
using two Prescription Exchange Services (PES), Script Exchange from eRx and Script Vault from MediSecure 
(Htat, Williams, & McCauley, 2015a). Using these PES services, prescribers can upload the electronic copy of 
the prescription for later download and dispense by the pharmacies. The use of electronic prescription exchange 
not only connects the two major healthcare providers such as clinicians and pharmacists, but it also paves the 
way to create a national medication repository. Such a repository would allow clinicians, pharmacists, aged care 
facilities and hospitals to see a combined list of prescribed and dispensed medications regardless of how many 
different doctors and pharmacies the patient has visited. However, current implementation of eTP is an 
expensive operation to maintain as an ongoing process for the nation. The associated electronic prescription fees 
for each prescription downloaded from PES used to be as much as AU$ 0.85 prior to achieving the 
interoperability between the two PES services. Some negotiations and cooperation between the Commonwealth, 
the Pharmacy Guild and the two PES operators managed to reduce the electronic prescription fees to AU$ 0.15 
per eligible prescription. This electronic prescription fees has, so far, been subsidised by the Commonwealth 
through a series of Community Pharmacy Agreements (CPA). However, the section 6.1.3 and Appendix-B of the 
current agreement, Sixth Community Pharmacy Agreement (6CPA), states that funding from 1st July 2016 and 
onwards will be subject to a cost-effectiveness assessment by an independent health technology assessment body 
as determined by the Minister ("The Pharmacy Guild of Australia", 2015). Since the eligibility criteria for this 
subsidy can be tightened or amended to the disadvantages of the pharmacies (i.e. current eTP implementation 
being a pharmacy user-pay system) ("FAQs", 2016), exploration of cheaper alternatives with comparable 
security measures to the current use of eTP is commendable. 
52
WHAT ETP STANDARDS AND SPECIFICATIONS MANDATES VS CURRENT 
ETPIMPLEMENTATION 
There are numerous standards and mandates regulating the management of medications in Australia. These 
include the Electronic Transaction Act (ETA) and various Acts and Regulations governing the Poisons and 
Therapeutic Goods. They have been repealed and/or amended at the Commonwealth as well as State and 
Territory level to accommodate the implementation of eTP in Australian healthcare. Figure 1 briefly depicts how 
these Acts and Regulations fit together to enable the current eTP implementation. It also demonstrates how the 
legislation and regulations in Australia are constructed and the complexity of this construction for eTP. The 
outermost circle represents the encompassing regulation for the entire nation. The next inner circle defines the 
regulations for each State and Territory amended as per jurisdictional legislative requirements. These two circles 
enable the use of electronic transactions at national, state and territory levels thus making the use of eTP and 
other electronic transactions possible. The third circle lists Acts and Regulations governing the Poisons and 
Therapeutic Goods for each jurisdiction which play a major role in enabling the use of eTP. The centre circle 
contains various standards and specifications developed reflecting those national and jurisdictional legislative 
requirements. It is named Dante’s 4 circles of eTP as the closer the circle is to the centre of the diagram the more 
eTP specific it becomes in a similar way the 14th century poet Dante Alighieri’s depiction of nine circles of hell 
(i.e. lower circles are for more severe sins). 
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Figure 1. Dante’s 4 circles of eTP 
The Commonwealth Electronic Transaction Act 1999 facilitates the use of electronic means and enables the use 
of electronic communications in dealings with government, business and community for the future economic and 
social prosperity of Australia. Various States and Territories amend/adopt this overarching Act to suit their 
jurisdictional legislative requirements. This jurisdictional ETA and various Acts and Regulations governing the 
Poisons and Therapeutic Goods for each jurisdiction dictate the requirements for eTP implementation in that 
jurisdiction. After all the eTP requirements of all jurisdictions have been considered, various standards and 
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specifications have been developed reflecting those requirements. Among these related standards and 
specifications, ATS4888 series and AS4700.3 primarily govern the implementation of eTP. Current eTP 
implementation developed in compliance with these standards and specifications is briefly depicted in Figure 2.  
 
Figure 2: Current electronic prescription transfer model using PES (Htat, Williams, & McCauley, 2015a) 
Although ATS4888.2 of the ATS4888 series particularly emphasizes on the platform independent model, it also 
includes specific details on securing electronic prescription information from the security of the data-at-rest 
perspective. It mandates that the electronic prescription to be encrypted using a symmetric key derived from the 
Document Access Key (DAK) before being stored on PES. DAK is the barcode printed on the paper prescription 
created by any eTP enabled electronic prescribing system. The current eTP implementation also makes use of 
DAK for authorizing access to the prescription stored on the PES and decrypting it after being downloaded from 
PES. In addition, section 7.3.3 of the ATS4888.2 strictly prohibits storing of DAK or any of its derived key on 
any stable storage (i.e. non-volatile storage) unless they have been encrypted using 128 bit encryption. Further 
details on securing electronic prescription from the security of data-at-rest perspective can be found in sections 
5.3.3 - 5.3.4, 5.3.6 - 5.3.7 and 7.3.3 of the ATS4888.2. These sections provide an overview of the security 
mechanism implemented using the DAK for safeguarding prescription information. Figure 3 briefly illustrates 
how this security mechanism works. 
 
Figure 3: DAK usage for storage and retrieval of prescription with PES (Standards Australia, 2013, Figure 19) 
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On the other hand, although ATS4888.2 contains specific details on securing prescription information from 
security of data-at-rest perspective, it mentions very little on securing the prescription information from data-in-
transit (i.e. data in motion) perspective. Both sections 5.3.5 and 7.3.3 of ATS4888.2 mention that securing 
prescription information from data-in-transit perspective entirely relies on the security and encryption 
mechanism of the implementation platform and the eTP technical specification for that platform. Research on 
eTP to date has not encountered any other standard or specification which includes further details on securing 
prescription information from data-in-transit perspective. Security in this context appears to be solely relying on 
existing industrial standards and best practices. Current implementation of eTP (i.e. both PES services) 
implements the simple Subscriber-Provider pattern instead of publishing their service endpoints using Endpoint 
Location Services (ELS) service infrastructure (Htat, Williams, & McCauley, 2016). Moreover, current eTP 
implementation does not utilize other eHealth infrastructural components such as Health Identifiers (HI) 
Services. Unfortunately, this leaves current eTP implementation considerable room for future improvement from 
security perspective. 
Another disadvantage of the current eTP is its associated ongoing cost, the electronic prescription fees. Although 
the combined effort of the Commonwealth, the Pharmacy Guild and the two PES operators could reduce the fees 
to AU$ 0.15 per eligible prescription, it is still a taxing expenditure for the nation on the long run. A recent 
survey by eRx found that pharmacies using eRx are dispensing 753,000 electronic prescriptions per day with up 
to 25 prescriptions per second during peak periods. When dispensing 753,000 prescriptions per day, it will cost 
the nation AU$ 112,950 a day for electronic prescription fees alone. 
 
 
Figure 4. Number of prescriptions over 10 year’s period 
 
 
Figure 5. PBS expenditure over 10 year’s period 
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Using statistics from the Pharmaceutical Benefits Scheme website, figure 4 and 5 depicts the number of 
prescriptions and PBS expenditure over the past 10 years. Based on figure 4 and 5, it is evident that although the 
PBS expenditure fluctuate slightly, the number of prescriptions increased steadily over the decade. 
Unfortunately, this indicates that unless less expensive alternatives are explored and utilized, the on-going 
expense associated with the use of electronic prescription will only cost more in future with increase in volume. 
At present, electronic prescription fees has been subsidised by the Commonwealth through a series of 
Community Pharmacy Agreements. However, despite the fact that current eTP implementation being designed 
as a pharmacy user-pay system ("FAQs", 2016), which party (among prescriber, dispenser and patient) will 
actually be liable to pay for this on-going cost when it is no longer subsidised by the Commonwealth and the 
ramification of this potential change is yet to be witnessed. 
PROPOSED ALTERNATIVE MOBILE SOLUTION 
The proposed mobile electronic prescription transfer application was designed to be a cheaper, if not completely 
cost-free, alternative with comparable security measures to the current eTP implementation using PES. This 
proposed solution makes use of the patient’s smartphone as the secured transfer mechanism for transferring 
electronic prescription instead of using PES. Figure 6 roughly depicts how this model works and its simplified 
operations using the patient’s smartphone in place of PES services whilst the rest of the operations remain the 
same as in the current eTP system. 
 
Figure 6: Electronic prescription transfer model using smartphones (Htat, Williams, & McCauley, 2015a) 
In securing the prescription information from the security of data-at-rest perspective, this model also makes use 
of DAK for encrypting the electronic prescription prior to transfer (i.e. to the patient’s mobile device) and 
decrypting at the pharmacy end. However, in this model, the prescriber’s Electronic Prescribing System (EPS) 
also transfers the DAK together with the electronic prescription to the patient’s smartphone for storage and 
transportation instead of using PES. The DAK is then encrypted using a 128 bit symmetric encryption, in 
compliance with the section 7.3.3 of the ATS4888.2, by the mobile electronic prescription transfer application 
prior to being stored on the smartphone. Upon arriving at the pharmacy, the mobile electronic prescription 
transfer application on the smartphone decrypts the DAK and transfers it together with the electronic 
prescription to the pharmacy’s eTP enabled Electronic Dispensing System (EDS). This transfer is to be done via 
Bluetooth communication although earlier research was conducted with the intention of using NFC technology 
instead. Once both the DAK and electronic prescription have been transferred to the pharmacy’s EDS system, 
the rest of the eTP operations such as decrypting the prescription using DAK, dispensing the medication and 
updating the National Prescriptions and Dispense Repository (NPDR) will continue in the same way as if in the 
current eTP implementation (Htat, Williams, & McCauley, 2015b). For the repeat prescription scenario, the 
pharmacy’s EDS will update the prescription information on the smartphone via the mobile electronic 
prescription transfer application. This model is designed to have minimal impact on the prescriber’s EPS and 
dispenser’s EDS systems in straightforward operations (i.e. simple prescribe and dispense scenario with no 
script-owing or script-request). How this proposed model’s security mechanism works and how it differs from 
the one using PES can be seen in Figure 7. 
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Figure 7: DAK usage for storage and retrieval of prescription in proposed approach (Htat, Williams, & 
McCauley, 2015b) 
Since the prescription information is stored on the patient’s smartphone, despite both the DAK and the electronic 
prescription being securely encrypted, it is still vulnerable to loss due to loss of the device on which it is stored. 
To ensure this sensitive information does not fall into the wrong hand, the remote data-wipe feature can be 
implemented as part of the mobile electronic prescription transfer application using Cloud-to-Device-Messaging 
(C2DM) from Google on Android platform, Google Cloud Messaging (GCM) on iOS platform and Windows 
Push Notification Services (WNS) on Windows phone platform. This will enable the device owner to remotely 
delete the prescription data stored on the device. Currently all major mobile OS platforms such as Android, iOS 
and Windows support remote wipe features for scenario like this. 
From the security of the data-in-transit perspective, this proposed model relies on the Bluetooth’s inbuilt security 
measures and governing standards for securing the prescription information in a very similar way current PES 
implementation relies on the implementation platform and its relevant standards for the security of the data in 
transit (Htat, Williams, & McCauley, 2015b). 
DISCUSSION 
The primary objective of the proposed mobile solution is to provide a cheaper, if not completely cost-free, 
alternative with comparable security measures. Therefore, the proposed alternative mobile solution intends to 
achieve the same level of security assurance as the current eTP implementation using PES by fulfilling the same 
security requirements mandated by the same standards and specifications.  
Being a national eHealth facility, current implementation of eTP using PES is considered to have complied with 
the legislative requirements of all the jurisdictions within Australia. However, the study on how it complies with 
those requirements and to which extent it complies with those requirements leads to interesting findings. For 
instance, whilst sections 32A, 32B and Appendix-K of the Western Australia’s Poisons Regulation 1965 
describes the fairly detailed criteria of an approved electronic prescribing system by CEO, the clause "in a 
manner of writing approved by the Secretary." in section 26 (1) (b) of the Victoria's Drugs, Poisons and 
Controlled Substances Regulations 2006 implies the use of electronic prescribing without further details on it. 
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Moreover, whilst the sections 37 (1A) (1B) and 51 (1A) (1B) (1C) of the Western Australia’s Poisons 
Regulation 1965 explicitly state the exemption from the requirement of prescriber’s signature on electronic 
prescriptions, sections 33 (5) and 34 (3) of the South Australia’s Controlled Substances (Poisons) Regulations 
2011 only mention that prescribers with adequate arrangements for the electronic transmission of prescriptions 
are permitted to transmit prescriptions electronically and it will be deemed to have been signed. Whilst one Act 
or regulation dictates something explicitly, the others imply the same meaning using somewhat catch-all 
statements and vice versa. Therefore, from the legislative approval/acceptance perspective, it is expected that the 
proposed mobile solution will be accepted as a viable alternative if it complies with all the same standards and 
specifications as the current eTP using PES. 
From the security of the data-at-rest perspective, the proposed solution also makes use of the symmetric 
encryption key derived from the DAK for securing the electronic prescription in the same way current eTP 
implementation using PES services does. This limits the impact of the change in transfer mechanism (i.e. 
patient’s smartphone instead PES) on other components of the eTP process such as prescribing, dispensing and 
updating NPDR etc. Then, in the proposed solution, the DAK is encrypted using a 128 bit symmetric encryption 
according to section 7.3.3 (i.e. Data Security Conformance Points) of the ATS4888.2 before being stored on the 
mobile device (Htat, Williams, & McCauley, 2015b). Since the proposed solution uses the same DAK for 
securing the electronic prescription and the DAK itself is stored encrypted according to the relevant security 
mandates, the proposed solution’s security measures are so far comparable to those of the current approach using 
PES. Moreover, in the same way the DAK scanned from the paper prescription is used for authorizing the 
pharmacy access to the prescription stored on the PES in the current eTP implementation, the DAK transferred 
from the mobile electronic prescription transfer application (i.e. the application from patient smartphone to the 
pharmacy’s EDS) authorizes the pharmacy to access the electronic prescription stored on the patient’s 
smartphone. Therefore, this authorisation mechanism of the proposed solution is also comparable to the current 
one being used. 
From the security of the data-in-transit perspective, the Bluetooth’s inbuilt security measures and governing 
standards upon which this proposed model depends on for securing the prescription information are well 
accepted by the industry and strictly governed by the Bluetooth Special Interest Group (SIG) and IEEE standard 
802.15.1-2005. With strict governance by these two reputable authority bodies (i.e. Bluetooth SIG and IEEE), 
the implementation platform specific security measures of the proposed model (i.e. using Bluetooth) can be 
considered comparable to those of the current eTP implementation using the Internet. 
Current eTP implementation using PES does not use any of the existing eHealth infrastructural components such 
as SMD, ELS and HI services although they can be effectively incorporated for better security, identification 
mechanism, consistency and reliability. Since the current approach using PES does not set very high standards 
for the proposed prescription transfer approach to live up to, this makes the proposed solution easier to 
implement and more acceptable to the industry. Although the primary objective of the proposed solution is to be 
a cheaper alternative with comparable security measures to the current approach using PES, it also has a few 
additional advantages over the current approach. First, this proposed solution puts the user in control of their 
sensitive information and allows them to prevent undesirable secondary use of that information by third parties. 
In addition, some useful features such as prescription expiration alert, last repeat alert, drug allergy alert and alert 
for harmful doses can also be implemented as part of the mobile electronic prescription transfer application. The 
ability to transfer the full history of patient’s medication from the patient’s mobile phone directly into the 
hospital system (i.e. once the interface has been implemented to integrate this mobile solution with the hospital 
information system) is just another benefit of this solution. Furthermore, without the requirement for the 
supporting network infrastructure this proposed solution will also be suitable for the remote regions of Australia 
where the network availability is limited or unreliable. 
CONCLUSION 
Before the 6CPA was officially signed, there were concerns and various speculations regarding what the new 
eligibility criteria will be for electronic prescription fees and how the subsidy will continue. Among them, eRx 
persuaded users with the no cost policy even for non-eligible scripts. But, some of its publications mention that it 
may not be able to maintain the cost neutral policy indefinitely but users would be given at least two month 
notice prior to any change being implemented to the price structure ("eRx slashes e-script pricing", 2010; 
O'Donoghue, 2012). So, effectively it does not even promise the users that it will remain cost neutral even with 
the current Commonwealth’s AU$ 0.15 contribution for each electronic prescription. How the use eTP will 
continue without the Commonwealth subsidy is rather an alarming thought. On the other hand, MediSecure 
seems to try using a scare tactics on users by implying that the eligibility criteria for electronic prescription fees 
will likely to be stricter in future ("How electronic prescription fee payment works?", 2015). For instance, from 
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certain point in time during the 6CPA agreement period, the Commonwealth’s AU$ 0.15 subsidy will only be 
applicable if the PES can share data with other eHealth components such as PCEHR and NPDR. From that 
aspect, only their product, Script Vault, is capable of such enhancement with minimal disruption to the services 
as it is the only PES service that fully complies with various eHealth and HL7 standards. When the 6CPA was 
officially signed, the section 6.1.3 and Appendix B of the agreement state that from 1st July 2016 and onwards 
this funding will be subject to a cost-effectiveness assessment by an independent health technology assessment 
body as determined by the Minister ("The Pharmacy Guild of Australia", 2015). Therefore, instead of living in 
fear of the potential change in the Commonwealth’s subsidy for the electronic prescription fees, this paper 
proposed a cheaper (i.e. potentially cost-free) alternative with comparable security measures to the options 
currently available. 
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